He et al.89 have categorized 775 breast cancer patients into 2 subgroups and revealed that the high methylation group showed higher expression of tumor-infiltrating CD8+ T cells and activated NK cells, but less PD-L1, PD-L2, TIM3, and CCR4 than patients in the lower RNA methylation group. The gene discussed is CD8A; the disease is neoplasm.